Medical treatment of Crohn's disease

被引：7

作者：

Harrison, J ^{[1
]}

Hanauer, SB ^{[1
]}

机构：

[1] Univ Chicago, Pritzker Sch Med, Dept Med & Clin Pharmacol, Sect Gastroenterol & Nutr, Chicago, IL 60637 USA

来源：

GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2002年 / 31卷 / 01期

关键词：

D O I：

10.1016/S0889-8553(01)00011-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Crohn's disease is not medically (and is rarely surgically) curable. Patients do, however, live a normal life span. The goal of therapy is to optimize the quality of life, minimize disease activity and disease-related complications, and avoid therapeutic toxicity.

引用

页码：167 / +

页数：19

共 158 条

[61] Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635
[62] Review article: safety of infliximab in clinical trials
Hanauer, SB
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 : 16 - 22
[63] Drug therapy - Inflammatory bowel disease
Hanauer, SB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) : 841 - 848
[64] HANAUER SB, 1993, AM J GASTROENTEROL, V88, P1343
[65] Hellers G, 1996, GASTROENTEROLOGY, V110, pA923
[66] Hermida-Rodriguez C, 1999, HEPATO-GASTROENTEROL, V46, P2265
[67] Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal?
Hyde, GM
Thillainayagam, AV
Jewell, DP
[J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (05) : 411 - 413
[68] Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance
Ierardi, E
Principi, M
Francavilla, R
Pisani, A
Rendina, M
Ingrosso, M
Guglielmi, FW
Panella, C
Francavilla, A
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (03) : 371 - 377
[69] Kapoor K, 1999, INT J CLIN PHARM RES, V19, P83
[70] Post-operative prophylaxis with 6-MP, 5-ASA or placebo in Crohn's disease: A 2 year multicenter trial.
Korelitz, B
Hanauer, S
Rutgeerts, P
Present, D
Peppercorn, M
[J]. GASTROENTEROLOGY, 1998, 114 (04) : A1011 - A1011

← 2 3 4 5 6 7 8 9 10 11 →